secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001818331-22-000080
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sema4 receives Nasdaq delisting notice and settles $42M payor dispute
---------------------------------------------------------------------

- Nasdaq notified Sema4 that its stock bid price below $1.00 for 30 consecutive days; has 180 days to regain compliance by June 26, 2023.
- Sema4 entered settlement agreement with a payor for $42M over alleged overpayments for multi-gene tests; to be paid in installments over four years.
- First installment of $15M due by Dec 31, 2022; payor releases claims 91 days after first payment.
- Payor also agreed to new three-year in-network participation agreement with GeneDx, LLC within 90 days.
- Sema4 intends to monitor bid price and consider options to resolve noncompliance; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833122000080/0001818331-22-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833122000080/smfr-20221228.htm
  HTML page:      https://secwatch.observer/filing/0001818331-22-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer